A prospective assessment of cardiac biomarkers for hemodynamic stress and necrosis and the risk of falls among older people: the ActiFE study

European Journal of Epidemiology

Volumn 31, Issue 4, 2016, Pages 427-435

  Dallmeier, Dhayana ^a,b   Klenk, Jochen ^c   Peter, Raphael S ^c   Denkinger, Michael ^d   Peter, Richard ^c   Rapp, Kilian ^e   Koenig, Wolfgang ^a,f,g   Rothenbacher, Dietrich ^c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d Agaplesion Bethesda Clinic Ulm   (Germany)

^e ROBERT BOSCH HOSPITAL   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Elderly; Falls; High sensitive troponin I; High sensitive troponin T; N terminal pro Brain Natriuretic Peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FALL RISK; FEMALE; FOLLOW UP; HEART MUSCLE NECROSIS; HEMODYNAMIC STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEX; VERY ELDERLY; BLOOD; FALLING; HEALTH SURVEY; HEMODYNAMICS; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; HEMODYNAMICS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN;

EID: 84934777092     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0059-9     Document Type: Article

References (44)

1. Tromp AM, et al. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001;54(8):837–44.
2. Dionyssiotis Y. Analyzing the problem of falls among older people. Int J Gen Med. 2012;5:805–13.
3. Bell AJ, Talbot-Stern JK, Hennessy A. Characteristics and outcomes of older patients presenting to the emergency department after a fall: a retrospective analysis. Med J Aust. 2000;173(4):179–82.
4. Vellas BJ, et al. Fear of falling and restriction of mobility in elderly fallers. Age Ageing. 1997;26(3):189–93.
5. Clerico A, et al. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clin Chim Acta. 2009;405(1–2):1–7.
6. van Diepen S, et al. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation. 2008;118(19):1946–52.
7. Stenhagen M, et al. Falls in the general elderly population: a 3- and 6- year prospective study of risk factors using data from the longitudinal population study ‘Good ageing in Skane’. BMC Geriatr. 2013;13:81.
8. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358(20):2148–59.
9. Thygesen K, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. 2012;33(16):2001–6.
10. Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem. 2007;53(4):552–74.
11. de Lemos JA, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304(22):2503–12.
12. deFilippi CR, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304(22):2494–502.
13. Wallace TW, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113(16):1958–65.
14. Agewall S, et al. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404–11.
15. Denkinger MD, et al. Accelerometer-based physical activity in a large observational cohort-study protocol and design of the activity and function of the elderly in Ulm (ActiFE Ulm) study. BMC Geriatr. 2010;10:50.
16. Dallmeier D, et al. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Clin Chem. 2015;61(2):389–99.
17. Lamb SE, et al. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53(9):1618–22.
18. World Health Organization. Falls Fact Sheet. 2012.
19. Wilson PW, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.
20. Di Angelantonio E, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120(22):2177–87.
21. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
22. D’Angelo G, Weissfeld L. An index approach for the Cox model with left censored covariates. Stat Med. 2008;27(22):4502–14.
23. Deandrea S, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology. 21(5): 658–68.
24. Carey BJ, Potter JF. Cardiovascular causes of falls. Age Ageing. 2001;30(Suppl 4):19–24.
25. Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59(1):148–57.
26. Rothenbacher D, et al. Prospective evaluation of renal function, serum vitamin D level, and risk of fall and fracture in community-dwelling elderly subjects. Osteoporos Int. 2014;25(3):923–32.
27. Majumdar SR, et al. Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects. J Clin Endocrinol Metab. 2012;97(4):1179–86.
28. Chung M, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(12):827–38.
29. Saunders JT, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011;123(13):1367–76.
30. Omland T, et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240-9.
31. Everett BM, et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women’s Health Study. Circulation. 2011;123(24):2811–8.
32. Sabatine MS, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J. 2009;30(2):162–9.
33. Scharhag J, et al. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J. 2005;150(6):1128–34.
34. Shave R, et al. Cardiac troponin I is released following high-intensity short-duration exercise in healthy humans. Int J Cardiol. 2010;145(2):337–9.
35. Horwich TB, et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation. 2003;108(7):833–8.
36. Baker JO, et al. Troponins: redefining their limits. Heart. 2011;97(6):447–52.
37. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142(9):786–91.
38. Motiwala SR, et al. Biomarkers in ACS and heart failure: should men and women be interpreted differently? Clin Chem. 2014;60(1):35–43.
39. Omland T, et al. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem. 2015;61(4):646–56.
40. Bodor GS, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem. 1997;43(3):476–84.
41. Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 1999;45(12):2129–35.
42. Aggarwal R, et al. Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies. J Rheumatol. 2009;36(12):2711–4.
43. Cox FM, et al. The heart in sporadic inclusion body myositis: a study in 51 patients. J Neurol. 2010;257(3):447–51.
44. Rittoo D. American College of Cardiology Foundation recommendations assume incorrectly that cardiac troponins T and I are equally cardiac specific. J Am Coll Cardiol. 2013;61(13):1466–7.